Tuberculosis (TB): Symptoms, Tests and Treatment

When to get medical help

Arrange a clinical assessment for an ongoing cough, unexplained weight loss, fever or night sweats, chest pain, unusual tiredness, or reduced appetite. A cough lasting three weeks or longer is a recognized warning sign, but three weeks is not a required waiting period. Seek advice earlier when you have a known exposure, concerning symptoms or a higher risk of serious illness. TB outside the lungs can cause other symptoms, including swollen lymph nodes, back pain, blood in urine, headache or confusion. [4]

When contacting a service, give the most urgent fact first: “I am coughing up blood,” “I am struggling to breathe,” or “The TB team told me I was exposed.” Then explain when the problem began. If you are awaiting results, name the clinic and the date of the test. Ask how to attend safely rather than assuming that the usual waiting-room arrangements apply.

Inactive TB and active TB disease are different

In inactive TB, bacteria remain in the body without causing TB disease. The person has no TB symptoms and cannot spread TB to other people. A clinician makes this diagnosis after considering a positive infection test and finding no evidence of active disease on the appropriate medical evaluation. Without preventive treatment, infection can progress to disease later; it is not possible to decide that risk simply from how healthy someone feels today. [2]

Having no symptoms does not by itself prove that TB is inactive. WHO notes that some people with TB disease have no noticeable symptoms and may still transmit infection. Others have mild symptoms for months. That is why clinicians combine the history, examination and relevant tests rather than using a simple “feel well versus feel ill” rule. [1]

Ask the team to write down the diagnosis in full. “TB infection,” “possible TB disease,” and “confirmed pulmonary TB” describe different stages or conclusions of an assessment. If the diagnosis is still uncertain, ask what evidence is missing and who will explain the next result. You should not have to translate an unfamiliar abbreviation into a decision about work, family contact or medicines.

How tuberculosis spreads through shared air

The main route is breathing air containing TB bacteria released by a person with infectious TB of the lungs or throat. Coughing, speaking and singing can release bacteria. They can remain suspended for hours, depending on conditions. Transmission is more likely indoors or where air circulation is poor than outdoors. The duration and setting of shared time matter, which is why the TB team asks about homes, workplaces and other places where people spend time together. [5]

TB is not spread by touching toilet seats, bed linen or another person’s hand, or by sharing food and drink. This does not mean that sitting indoors together is risk-free: people sharing a meal also share air. Separate the route of infection from the social activity. Excessive cleaning of belongings cannot replace a TB-specific plan for treatment, shared air and contact assessment. [5]

A useful way to describe a possible exposure is to explain the room, the people present and the pattern of visits. “We worked beside each other in a small office most afternoons” is more informative than “I know the person.” You do not need to calculate your own exposure score. Give the investigators the information you remember and clearly identify anything that is uncertain.

Being exposed does not make someone immediately contagious. Contact investigations identify people who may need assessment, and the health team decides whom to contact based on the circumstances. If you learn that you spent time near someone with active TB, contact a healthcare professional or local TB service even if you feel well. Tell them approximately when the contact happened and whether you currently have symptoms. [9]

Who needs particular attention after exposure?

There are two different risk questions: how likely someone is to encounter TB bacteria, and how likely infection is to become disease. Close contact with infectious TB, time in settings where transmission occurs, and residence or travel in places with more TB can increase exposure. HIV, some immune-suppressing medicines, organ transplantation, severe kidney disease, diabetes, silicosis and low body weight can increase vulnerability after infection. Having a risk factor does not mean a person has TB. [8]

Tell the clinic about planned treatment that suppresses immunity, as well as treatment you already receive. Name the medicine or bring its packaging rather than describing it only as an injection or a steroid. Also explain whether earlier TB treatment was completed, interrupted or never started. These details belong in a private clinical conversation; they should not become assumptions about someone’s nationality, character or behavior.

HIV and diabetes need coordinated care

HIV increases the risk that TB infection will progress to disease. It can also weaken the immune response measured by infection tests, so a negative result may need further investigation. CDC advises people with HIV to discuss TB testing and recommends HIV testing when a person with TB does not know their HIV status. Both conditions can be treated, but the teams need to coordinate the plan. A negative screening result should not dismiss ongoing symptoms in someone with HIV. [22]

Diabetes also increases the chance of becoming ill after TB infection. If you have diabetes, tell the TB service which medicines you use and tell your diabetes clinician about TB treatment. Some TB medicines interact with diabetes medicines. The practical goal is one coordinated plan, with clear responsibility for reviewing both conditions, rather than two clinics making changes without knowing what the other prescribed. [23]

Children and pregnancy need individual advice

If children have been exposed, tell the TB team promptly, especially when a child is younger than five. Young children can progress to disease more quickly and are more vulnerable to severe forms such as TB meningitis. Their assessment and preventive treatment decisions differ from adult care. A well-looking child or a parent’s reassuring test result is not a substitute for arranging that child’s assessment after relevant exposure. [25]

Tell the team if you are pregnant, might be pregnant or are breastfeeding. Active TB during pregnancy needs prompt treatment, with medicines selected for that situation. For inactive TB, the timing of treatment depends on individual risk; some people can wait until after delivery, while others need earlier treatment. Do not postpone assessment or change medicines on your own because of pregnancy. Ask the TB and maternity teams to agree the plan together. [24]

What TB tests can and cannot tell you

An infection test and a test looking for active disease answer different questions. Blood and skin tests detect an immune response associated with TB infection. A positive result usually needs further evaluation to distinguish inactive infection from disease. Negative results do not always end the investigation, particularly after recent exposure, with symptoms or with impaired immunity. Testing is most useful when chosen for the person’s risk and the question being asked, rather than repeated without a clear reason. [10]

Blood tests and skin tests

A TB blood test, often called an IGRA, examines how a blood sample responds to TB proteins. It normally requires one visit for the sample, although results and follow-up still need arranging. BCG vaccination does not affect the blood test, so CDC prefers it for people who have received BCG and for people who may struggle to return for a skin-test reading. Ask which test your local service offers and how you will receive the result. [11]

A traditional tuberculin skin test involves an injection just under the skin and a return visit two to three days later. A trained professional measures the reaction and interprets it in context. A photograph or a judgment that the arm “looks normal” does not replace that reading. If you cannot return in the specified window, contact the clinic because the test may need repeating. Mention any previous severe skin-test reaction before another test is placed. [12]

After a recent infection, a blood test can be negative before the immune response becomes detectable. CDC recommends repeat testing eight to ten weeks after the last exposure for contacts whose initial blood test was negative. The team sets the timing for your circumstances. An indeterminate, borderline or invalid result is not the same as a clearly negative result; another blood test or a skin test may be needed. Symptoms still require assessment while this is being sorted out. [31]

Chest imaging and samples

A chest X-ray may suggest pulmonary TB but cannot confirm the diagnosis by itself. Sputum, the phlegm coughed from the lungs, may be tested using microscopy, molecular tests and culture. Molecular tests can provide rapid information, while culture and drug-susceptibility testing answer additional questions. A negative smear does not rule out TB, and some people are diagnosed despite negative cultures when the overall clinical evidence supports disease. [13]

TB outside the lungs may require different samples, such as urine or tissue, depending on the suspected site. The same person can have more than one area affected. Your team should explain why a particular sample is needed and how it will be obtained; a routine sputum result cannot answer every question about disease elsewhere in the body. [3]

Follow the service’s exact collection instructions and ask where to produce a sputum sample. Clinical guidance calls for appropriate airborne precautions and a suitable collection location. If you cannot bring up phlegm, tell staff instead of improvising a collection method in a shared waiting area. The team can decide whether another method or sample is needed. [13]

Before leaving, establish three practical details: who will receive each result, when you should expect an explanation, and whom to call if it does not arrive. If you see results in an app before speaking with the team, copy the exact test name and date into your questions. Avoid interpreting “pending,” “not detected” and “negative” as interchangeable descriptions of a finished evaluation.

Treatment depends on the diagnosis and the medicines that will work

Preventive treatment for inactive TB

Preventive treatment aims to stop inactive infection developing into active disease. It is worthwhile discussing even when you feel well. Several treatment plans exist, and their length and schedule differ. The written plan should identify the medicines, when to take them, the planned course, possible side effects and the clinician supporting you. Tell the team about difficulties obtaining medicines, clean water, food or transport before those difficulties interrupt care. [14]

Active TB must be excluded before starting a latent-infection regimen. In the United States, CDC generally prefers suitable short rifamycin-based courses over longer isoniazid-only courses, but suitability depends on the person and possible interactions. Rifampin and rifapentine can affect other medicines, including hormonal contraception. Ask a clinician or pharmacist whether additional or alternative contraception is needed, and bring a complete list of prescribed, nonprescription and herbal products. A shorter course is not automatically the right course for everyone. [16]

Combination treatment for active TB disease

Active TB is treated with a combination of medicines selected by the clinical team. Taking the full combination as prescribed helps kill the bacteria and reduce the chance of resistance. Feeling better is not proof that treatment is finished. Stopping early or taking only some of the medicines can allow illness to return and make subsequent treatment more difficult. Treatment commonly lasts months, but there is no single duration that applies to every form of TB or every person. [15]

Ask for a schedule you can use on an ordinary working day and on weekends. Check what to do if a dose is missed, you vomit after taking it, or a refill will run out before the next appointment. Do not guess a replacement dose or double up without instructions. Record what actually happened, including uncertainty, and contact the team for advice based on your particular regimen. [15]

Make the plan concrete before the first difficult day. Put the clinic’s daytime and out-of-hours contacts somewhere you can find quickly. Decide how prescriptions will be collected if you cannot leave home. If a relative helps, agree whether their role is collecting medicine, reminding you, taking notes or attending an appointment. Helpful support has a defined job; it should not require them to make clinical decisions.

Monitoring and side effects

Monitoring is part of treatment, not an optional extra after symptoms improve. For inactive TB, CDC recommends at least monthly review of adherence, symptoms and adverse effects; blood-test monitoring is tailored to risk and findings. Bring new symptoms to the team between scheduled visits when needed. Ask whether your next appointment is for a medicine review, laboratory testing, a sample collection or several of these, so that you prepare correctly. [16]

Rifampin or rifapentine can cause an expected orange color in urine, sweat or tears and may stain soft contact lenses. Brown urine accompanied by illness or yellowing of the eyes is a different concern and should not be dismissed as that expected color change. Ask your pharmacist to explain the effects of your actual medicines. Do not assume that a friend’s experience applies to a different prescription. [17]

Keep a short medicine log with the date, what you took and any problem you want to report. Write “vomited after the evening tablets” rather than diagnosing yourself with an allergy. Keep medicine names and packaging available for a phone call. If you cannot tell which tablet was taken, say so; an accurate account of uncertainty is more useful than a confident guess.

What drug-resistant TB means

Drug resistance means that particular medicines no longer work against the TB bacteria; it does not mean that a person’s body has become resistant. Someone can acquire resistant bacteria directly from another person. Resistance can also arise when treatment is inappropriate, medicines are unavailable or poor quality, or a prescribed course is not adequately completed. It is therefore wrong to assume that every resistant infection is the patient’s fault. Care needs a TB expert and appropriate laboratory testing. [18]

Multidrug-resistant TB, or MDR-TB, is resistant to at least isoniazid and rifampicin, also called rifampin. Rifampicin-resistant TB, or RR-TB, describes resistance to rifampicin whether or not other resistance is also present. These labels help teams organize further testing and treatment. They do not tell a reader which drugs to buy or how long an individual course should last. Different resistance patterns and medical circumstances require different plans. [19]

If someone whose TB you were exposed to has drug-resistant disease, tell your own clinician. Do not borrow their medication or assume that a standard preventive course is appropriate. When resistance is found during your treatment, ask which results changed the plan, which medicine instructions now apply and when the revised plan will be reviewed. Keep the superseded prescription separately so that it cannot be mistaken for the current one. [18]

A practical plan for home, work and treatment support

Let the TB team decide when precautions can end

For potentially infectious lung or throat TB, the team may advise staying away from work or school, avoiding close contact, sleeping separately, covering coughs and improving ventilation to the outdoors. Follow its instructions for your actual home. Follow-up assessments help determine whether treatment is working and whether you can still transmit TB. Do not return to work or social visits until the team says it is safe. A fixed number of days or feeling better cannot serve as universal clearance. [20]

Ask specifically about masks, travel to appointments, shared bathrooms, bedrooms and anyone in the household who needs extra protection. If there is no separate bedroom, windows cannot be opened safely, or staying home threatens housing or income, say so immediately. The plan needs to be workable in the place you actually live. For broader household hygiene principles, see our guide to infection control, hand hygiene and safer care; your TB team’s airborne precautions remain the instructions to follow for TB.

Contact tracing is another part of protecting a household or workplace. Be ready to describe regular contacts, locations and routines during the period the team asks about. Staff decide which contacts need assessment; you do not have to diagnose other people or issue a warning to every acquaintance yourself. Ask the local service how it handles confidentiality and communication. Do not assume that another country’s privacy or reporting rules apply where you live. [9]

Support should solve barriers, not assign blame

Directly observed therapy, or DOT, involves a health worker observing doses and supporting treatment. Video DOT can provide this remotely, either live or through recordings. CDC recognizes video DOT as an alternative to in-person DOT in appropriate U.S. care. The choice should consider clinical needs, privacy, reliable internet, access to a suitable device and personal circumstances. Ask what happens when the connection fails and how to report symptoms between sessions. [29]

TB care should include understandable information, respectful communication and help with barriers to completing treatment. WHO describes education and counselling as a continuing conversation, including worries about side effects, finances, housing and emotional distress. Ask for an interpreter or clearer written instructions when needed. If you are afraid of losing work, being judged or telling someone at home, bring that concern to the care team; it is relevant to making treatment possible. [28]

For a support conversation, start with the obstacle rather than a general promise to “try harder.” Examples are: “My shift begins before the clinic opens,” “I do not have a private place for video calls,” or “I cannot pay for transport this week.” Then ask who can help and when you should hear back. Write down the agreed next step so the problem does not have to be explained from the beginning at every visit.

If a family member wants to help, agree how much information you want shared and invite them to a discussion when useful. WHO emphasizes dignity, privacy and involving patients in their own care. TB is not evidence of personal failure. Practical help and respectful conversation are more useful than blame, threats or asking the person to prove that they deserve care. [28]

Prevention, BCG vaccination and travel

BCG is a TB vaccine used in many countries, particularly to protect young children against severe disease such as TB meningitis. It does not reliably prevent every TB infection or every case of disease, and protection can weaken over time. Vaccination policies vary by country and risk group. A childhood BCG record does not remove the need to report an exposure, investigate symptoms or follow precautions. [21]

For travel, the important question is the type of exposure expected. Healthcare work, prolonged stays in high-transmission settings, or work in congregate facilities may justify pre-travel and post-travel testing. Most low-risk travelers do not need routine screening solely because they traveled. Discuss the itinerary and work setting with a travel-health or occupational-health service early enough to arrange a useful baseline when indicated. Travelers providing patient care should ask about respiratory protection and infection-control arrangements at the destination. [26]

Healthcare workers should follow their employer’s occupational-health process and local requirements. In the United States, CDC recommends baseline screening on hire; routine annual testing is generally not recommended without known exposure or ongoing transmission, although local regulations can differ. This is an example of why a universal annual-testing rule is misleading. A workplace exposure or new symptoms need timely review through the relevant process rather than waiting for a routine screening date. [27]

For an upcoming trip or job change, prepare the dates, destination, type of work and any existing TB records before the appointment. If you are already being evaluated or treated, ask your TB team whether travel is appropriate and how care would continue. Do not let a ticket, deadline or employer form become the reason you miss the clinical conversation. Keep a copy of any agreed care-transfer arrangements.

Getting useful answers and keeping records

CDC encourages asking about the recommended treatment, medicine instructions, adverse effects, costs and available support. Tell the clinician about previous positive tests and whether earlier treatment was completed. These discussions are useful before treatment and whenever circumstances change. Ask for the explanation in language you understand, and identify the unanswered question that matters most to you rather than leaving with a list of unfamiliar drug abbreviations. [30]

At the end of an appointment, repeat the plan in your own words: what you will do today, what the clinic will arrange, and what should trigger an earlier call. Separate agreed instructions from issues still awaiting a result. If you have written “ask about return to work,” it should not later be mistaken for permission to return. Date each version and keep only the current medicine schedule in daily use.

A TB blood or skin test can remain positive after successful treatment. Ask for written records of the original result, evaluation and completed course; another positive infection test does not automatically establish new disease or treatment failure. New symptoms or a later exposure still deserve assessment, and the old records help the clinician understand what has already happened. [10]

Before the treatment service discharges you, ask who to contact for future questions and what symptoms should bring you back. Describe any ongoing difficulty with breathing, stamina or daily tasks instead of assuming that the completion certificate answers every recovery question. Keep copies of the final plan where you can retrieve them after moving home, changing jobs or changing healthcare providers.

Frequently asked questions about tuberculosis

Can inactive TB infect my family?

No. Inactive or latent TB is not contagious. The important point is that the diagnosis follows an appropriate evaluation for active disease; feeling well alone is not sufficient. Treatment may still be advised to prevent future illness. If new symptoms develop, contact your clinician rather than assuming that the earlier diagnosis explains them. [2]

Does a negative TB test mean I can ignore a persistent cough?

No. A negative infection test cannot reliably exclude every case of TB, especially with recent exposure or impaired immunity. An indeterminate result is also not a reassuring negative. Discuss persistent or worsening symptoms with a clinician and follow any recommended further testing. Do not wait for a planned repeat screening test if you become unwell. [31]

Does a BCG scar mean I am protected?

BCG does not guarantee protection against infection or disease. Tell the clinic about vaccination because it can affect a skin-test result; blood tests are not affected in the same way. Exposure and symptoms still need assessment regardless of whether you remember vaccination or have a scar. [21]

When can I return to work or see friends?

For potentially infectious TB, the treating and public-health teams decide when restrictions can end. The answer depends on your evaluation and response to treatment. Follow the clearance instructions you receive rather than a fixed number of days quoted online. Ask for documentation if your employer or school needs it. [20]

Can drug-resistant TB be treated?

Yes, treatment is possible, but it requires specialist care and medicines chosen for the resistance pattern. It may be more complicated than treating drug-susceptible TB. Laboratory results, previous treatment and your overall health guide the plan; a resistance label alone cannot predict an individual’s outcome. [18]

Why take preventive medicine when I feel healthy?

Inactive TB treatment is intended to prevent future disease, rather than relieve a symptom you have now. Discuss your individual risk, the benefits and possible adverse effects, and which option you can realistically complete. Ask the team to review concerns about taking medicine for months instead of quietly dropping the plan. [14]

What should I bring to my first TB appointment?

Bring available test reports, previous TB treatment records, vaccination information, a medicine list and a short account of symptoms or exposure. Also bring your main practical concern, such as work hours, transport or caregiving. You can ask about costs and support at the same visit. Missing a document should not stop you seeking needed care. [30]